Strides receives USFDA nod for Potassium Chloride for Oral Solution

Strides receives USFDA nod for Potassium Chloride for Oral Solution

by admin- Monday, March 15th, 2021 03:46:37 PM

Strides Pharma Science has introduced that its stepdown fully owned subsidiary, Strides Pharma Global Pte. Ltd, Singapore, has acquired popularity of Potassium Chloride for Oral Solution USP, 20 mEq from the US Food & Drug Administration (USFDA). The product is bioequivalent and therapeutically equal to the Reference
Listed Drug (RLD), Potassium Chloride for Oral Solution USP, 20 mEq, of Pharma Research Software Solution, LLC.

News Updates